Orchestra BioMed Holdings, Inc
Price
FilingsNewest: Form 4, insider tradeNov 20 →Insiders8 insiders bought $6.5M in 13 open-market buys. 3 insiders sold $439,182, 6 of 7 sales on a 10b5-1 plan.→HoldersRTW Investments 15.6%Perceptive 8.2%BlackRock 4.1%→Financing →PeersClosest companies: EWTX, GUTS, TNYA→
From the filings
Figures
- Revenue
- $31.2Mlast 12 months
- Net income
- −$57.0Mlast 12 months
- Operating cash flow
- −$58.3Mlast 12 months
- Cash and equivalents
- $27.8Mat the last balance sheet
- Total debt
- $15.0Mat the last balance sheet
- Shares outstanding
- 61.5M shareson issue
Filings, newest first
- Nov 204Insider trade
- Nov 124Insider trade
- Nov 1010-QQuarterly report
- Nov 98-KMaterial agreement
- Nov 6424B5Offering prospectus
- Nov 5424B5Offering prospectus
- Oct 18-KRegulation FD disclosure
- Sep 88-KRegulation FD disclosure
- Aug 1010-QQuarterly report
- Jun 238-KShareholder vote
- Mar 1210-KAnnual report